Browsing Category

DCAT Member Company Community

140 posts

DCAT Awards Grants To Student Scientists at the 2026 Regeneron International Science & Engineering Fair   
By

By
The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of six projects who participated in the Regeneron International Science & Engineering Fair (Regeneron ISEF), the…

ICYMI: Production to Prescription Podcast: A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis 
By

By
The blockbuster success of the GLP-1 agonists and related drugs has renewed interest in peptide-based therapeutics, but how is the manufacturing technology evolving?  In the latest episode of the DCAT Value Chain Insights podcast, Production to Prescription, a…

New DCAT Member Company Alert
By

By
Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view…

People on the Move
By

By
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…

New Episode: Production to Prescription Podcast: What Tops the Industry’s Sustainability Agenda for 2026?
By

By
As bio/pharma companies and their suppliers set and implement their sustainability strategies, what issues top the industry’s sustainability agenda? Decarbonizing, standardized reporting of value-chain emissions, and coalescing talent and technology…

ESG Update: DCAT Member Companies in the Community  
By

By
The latest ESG (environmental, social and governance)news from DCAT Member Companies on how they are making an impact globally and in their local communities. Have a ESG news announcement to share for…

New Episode: Production to Prescription Podcast: 2025: The Bio/Pharma Industry’s Year in Review
By

By
Without question, evolving US tariff and trade policy was the story of the year in 2025, and how such policy will be implemented looms large. At the same time, the…

ICYMI: 2026 DCAT Value Chain Insights Editorial Calendar Now Available
By

By
In case you missed it, the 2026 DCAT Value Chain Insights Editorial Calendar is now available.  The feature schedule for 2026 focuses on major themes impacting the business of bio/pharmaceutical…

ESG Update: DCAT Member Companies in the Community 
By

By
The latest ESG (environmental, social and governance) news from DCAT Member Companies on how they are making an impact globally and in their local communities. Have a ESG news announcement…

ICYMI: Production to Prescription Podcast: Drug Launches & Approvals in 2025: The Blockbuster Contenders 
By

By
Each year, the promise of new market entries loom in the bio/pharmaceutical industry. Which products, launched or approved thus far in 2025, may be potential blockbusters (defined as drugs with sales of $1…